CEVA Together, beyond animal health

  • Corporate Website Corporate Website
  • Africa Africa
  • Argentina Argentina
  • Asia Asia
  • Australia Australia
  • Belgium Belgium
  • Brazil Brazil
  • Bulgaria Bulgaria
  • Canada (EN) Canada (EN)
  • Chile Chile
  • China China
  • Denmark Denmark
  • Egypt Egypt
  • France France
  • Germany Germany
  • Greece Greece
  • Hungary Hungary
  • Indonesia Indonesia
  • Italia Italia
  • India India
  • Japan Japan
  • Korea Korea
  • Malaysia Malaysia
  • Mexico Mexico
  • Middle East Middle East
  • Netherlands Netherlands
  • Peru Peru
  • Philippines Philippines
  • Poland Poland
  • Portugal Portugal
  • Romania Romania
  • Russia Russia
  • South Africa South Africa
  • Spain Spain
  • Sweden Sweden
  • Thailand Thailand
  • Tunisia Tunisia
  • Turkey Turkey
  • Ukraine Ukraine
  • United Kingdom United Kingdom
  • USA USA
  • Vietnam Vietnam

You are leaving the country website to access another site in the group.

Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

  • Corporate Website Corporate Website
  • Africa Africa
  • Argentina Argentina
  • Asia Asia
  • Australia Australia
  • Belgium Belgium
  • Brazil Brazil
  • Bulgaria Bulgaria
  • Canada (EN) Canada (EN)
  • Chile Chile
  • China China
  • Denmark Denmark
  • Egypt Egypt
  • France France
  • Germany Germany
  • Greece Greece
  • Hungary Hungary
  • Indonesia Indonesia
  • Italia Italia
  • India India
  • Japan Japan
  • Korea Korea
  • Malaysia Malaysia
  • Mexico Mexico
  • Middle East Middle East
  • Netherlands Netherlands
  • Peru Peru
  • Philippines Philippines
  • Poland Poland
  • Portugal Portugal
  • Romania Romania
  • Russia Russia
  • South Africa South Africa
  • Spain Spain
  • Sweden Sweden
  • Thailand Thailand
  • Tunisia Tunisia
  • Turkey Turkey
  • Ukraine Ukraine
  • United Kingdom United Kingdom
  • USA USA
  • Vietnam Vietnam

You are leaving the country website to access another site in the group.

Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

  • Who are we?
    • Company overviewHistory of Ceva-PhylaxiaOur visionOur valuesResearch and developmentProductionEthics and Compliance programGlobal presence
  • Products
    • Companion AnimalsCattleSheep and goatsSwinePoultryProducts developed and manufactured in Hungary
  • News & Media
    • MediaNews
  • Responsibility
    • Annual Energy Consumption ReportBusiness and scientific partnershipsCeva and the communityHealth, happy people and animalsFeeding the worldProtecting global public health
  • Careers
    • Our Job offersYour personal growthOur recruitment process
  • Pharmacovigilance
  • GENERAL TERMS AND CONDITIONS
    • GENERAL TERMS AND CONDITIONS for purchasing goods and services
Home
>
News & Media
>
Media

Media

Latest Media publications

18 August 2016

Ceva posts strong double-digit organic growth once again in first half of 2016 >

Consolidated sales of the Ceva Group reached €455m at the end of June 2016.

9 June 2016

Ceva acquires Biovac >

Move will reinforce group’s AMR strategy to find alternative solutions to use of antibiotics.

27 April 2015

Ceva Posts Strong Double-Digit growth again in 2014 >

Consolidated sales of the Ceva Group reached €766m at the end of 2014, representing growth of 23% and +14.1% at a constant perimeter and exchange rates.

26 November 2014

Another investment of HUF 2 billion from Ceva-Phylaxia >

Ceva-Phylaxia, one of the veterinary market leaders expands its vaccine production plant again.

22 July 2014

50 billionth domestic poultry vaccine reaches completion >

As a market leader, the so-called immune complex vaccines against one of the most frequent catching disease that affects chickens are produced in Hungary.

24 June 2014

Press Release: The new canine disease can be prevented >

24 June 2014

Press Release: The big tick map is to come >

18 April 2013

Ceva records double digit growth for 3rd. successive year >

14% growth pushes sales beyond 600 M€ for first time

8 October 2012

Innovation drives Ceva's growth >

You can find in the attachment the mid-year result 2012 of the Ceva Group

Previous
  • 1
  • 2
Next
Also in the News & Media section
  • Media
  • News

Back to top

Contact us

1107 Budapest Szállás utca 5.

(36 1) 262 95 05 (36 1) 262 95 05 (36 1) 260 38 89 (36 1) 260 38 89

ceva-phylaxia@ceva.com

Our Product websites

  • Vectra
  • Vectormune
  • Transmune
  • A kiegyensúlyozott és stresszmentes cicákért
  • A kiegyensúlyozott és stresszmentes kutyákért
  • See all our products

All our websites  

Ceva Corporate website  

Change language

  • En
  • Hu

Find us on social networks :

  • © Ceva 2022
  • Sitemap
  • Cookies Policy
  • Privacy policy
  • RSS
  • Contact
  • Pharmacovigilance
  • Legal notice